Desmopressin nasal spray regulatory update

FDA’s Bone, Reproductive and Urologic Drugs advisory committee voted 14-4 in favor of the risk-benefit profile of Serenity’s desmopressin nasal spray to treat nocturia in adults who awaken >=2 times p...